您好,欢迎来到上海士研管理咨询有限公司
产业峰会 演讲局 专家智库服务 峰会活动服务 整合营销服务
  • 产业峰会:
    以专业团队对产业和市场客观详实地调研为前提,拥有战略性、系统性、全球性的基因,汇集了领导者关注的热点话题与领袖代表,为您提供“一站式”的对话、分享、社交平台!
  • 演讲局:
    致力于为全球企业和机构提供主题演讲家、高管大师班、董事会顾问,每项服务都提供了一种更深入、更具互动性的体验,尤其是针对较小的精选受众和关键个人。我们拥有最具影响力的商业领袖和顶级专家的资源,他们是各自领域的最杰出的代表。我们的团队由经验丰富的演讲和活动经理组成,我们注重建立长期而深入的伙伴关系。
  • 专家智库服务:
    中国领先的行业专家知识信息服务供应商,为需要专业洞见的商业决策者匹配具有一手经验的行业专家,助力他们以更加明确的目标和坚定的信心做出决策。我们有60万余名专家顾问遍布二十多个行业,而且每天还在增加!
  • 峰会活动服务:
    致力于成为全球最专业的产业峰会活动提供商,为企业和机构的产业性峰会活动提供一站式专业服务,包括调研策划、定制邀请、营销推广、运营组织、项目管理、直播与数字化会议等,每项服务都由经验丰富的专业团队匹配长期沉淀的产业资源予以卓越执行,我们注重建立长期而深入的伙伴关系。
  • 整合营销服务:
    致力于成为全球领先的2B营销服务机构,聚焦产业高端活动、内容、渠道的建设与沉淀,为客户提供一站式整合营销解决方案,助力企业线上线下获客与品牌筑造。我们深信专业团队匹配产业资源带来卓越执行,我们注重建立长期而深入的伙伴关系。
嘉宾信息
发布时间: 2022 - 11 - 23
点击次数: 0
所属职位:
所属公司:
个人简介:
俞康信,西安交通大学药学管理硕士,曾任正大天晴药业集团股份有限公司常务副总裁。俞康信先生任公司常务副总裁以来,带领企业开展组织变革、降本增效、优化运营,确保公司在急剧变化的行业背景和激烈的行业竞争下,管理效能显著提升,行业竞争力进一步增强,并积极探索医药行业转型升级新模式,加大与国内大型医院和行业学协会的深度合作,对正大天晴的健康发展和中国医药行业进步做出了重要贡献。Kangxin YU, master of pharmaceutical management of Xi'an Jiaotong University. Mr. Yu has led the enterprise to carry out organizational reform, reduce costs and improve efficiency, optimize operation, ensure that the company's management efficiency is significantly improved and the industry competitiveness is further enhanced under the rapidly changing industry background and fierce industry competition, actively explore new modes of transformation and upgrading of the pharmaceutical industry, increase in-depth cooperation with large domestic hospitals and industry associations, It has made important contributions to the healthy development of CTTQ and the progress of China's pharmaceutical industry.
发布时间: 2022 - 11 - 23
点击次数: 0
所属职位: 副总裁、制造管理中心主任
所属公司: 上海医药集团股份有限公司
个人简介:
张耀华,1973年7月出生。复旦大学高分子化学专业毕业。现为上海医药集团股份有限公司副总裁、制造管理中心主任,并在上海医药集团股份有限公司附属公司兼任董事等职务,同时兼任中国化学制药工业协会副会长等职务。Zhang Yaohua, born in July 1973, has a bachelor’s degree in Polymer Chemistry from Fudan University. He is currently a vice president & director of manufacturing management center of the Company and holds directorship in certain subsidiaries of the Company. He also served as a vice president of China Pharmaceutical Industry Association.
发布时间: 2022 - 11 - 23
点击次数: 0
所属职位: 首席商务官
所属公司: 百济神州
个人简介:
殷敏女士于2022年1月加入百济神州,担任百济神州大中华区首席商务官。殷敏女士拥有近二十年医药行业从业经验,对医疗健康领域的发展和特性有深刻的洞察。殷敏女士于2006年至2021年就职于阿斯利康,历任高级财务规划经理、海外区域市场战略项目负责人、中国/香港合规部副总裁、商业及多元化渠道部副总裁等多个重要岗位。2018年6月,殷敏女士被委任为阿斯利康中国副总裁,肿瘤业务部负责人,并于2019年1月升任阿斯利康中国肿瘤业务部总经理。殷敏女士毕业于上海交通大学,主修金融贸易以及计算机科学,于2002年获得中欧国际工商学院硕士学位。Eva Yin joined BeiGene in 2022 as Chief Commercial Officer, BeiGene Greater China. Ms. Yin has nearly 20 years of experience in the pharmaceutical industry, having held various positions in finance, compliance, commercial & diversified channels, gaining insights into the development and characteristics of the healthcare industry.Prior to BeiGene, Ms. Yin worked at AstraZeneca from 2006 to 2021, where she held various positions including Senior Business Finance Manager, Area Strategy Project Lead for International markets, Vice President of China & HK Compliance, and Vice President of Commercial & Diversified Channels. By Jan 2017, Eva expanded her responsibility to oversight of AstraZeneca HK & Macau. She was appointed AstraZeneca China Vice President, Oncology, in 2018, and promoted to General Manager of Oncology, AstraZeneca China, in 2019.Ms. Yin graduated from Shanghai Jiao Tong University, majoring in finance & trading and computer science. She obtained her full-time MBA from CEIBS (China Europe International Business School) and completed an exchange program at London Business School in 2002.
发布时间: 2022 - 11 - 23
点击次数: 0
所属职位: 副总经理
所属公司: 江苏恒瑞医药股份有限公司
个人简介:
沈亚平,毕业于广州暨南大学(学士)及加拿大渥太华大学(博士)。曾担任加拿大Inflazyme Pharmaceuticals Ltd公司医药化学和工艺总监,Lipont Pharmaceuticals Inc公司总经理,美国Chemwerth Inc公司中国区总经理。2012年4月加入恒瑞医药,担任董事长助理,2013年4月起任公司副总经理,分管国际仿制药事务,负责欧美日及海外市场的原料药和制剂产品的注册申报,产品维护,和上市销售。在著名国际专业期刊杂志发表高水平文章13篇,获14项美国专利.Yaping Shen, graduated from Guangzhou Jinan University (B.Sc.) and University of Ottawa (Ph.D.). He has served as Director of Medicinal and Process Chemistry, Inflazyme Pharmaceuticals Ltd, Canada, General Manager of Lipont Pharmaceuticals Inc., and General Manager of Chemwerth Inc., China. In April 2012, he joined Jiangsu Hengrui Medicine Co., Ltd as the chairman Assistant. Since April 2013, he has served as Vice President of the company. He is in charge of international generics business, responsible for registration and marketing API and finished dosages for European, US, Japanese and overseas markets. He has published 13 high-level articles in international professional journals and is an inventor for 14 US patents.
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务